ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group.

MLA

Cortese, Samuele, et al. “ADHD Management during the COVID-19 Pandemic: Guidance from the European ADHD Guidelines Group.” The Lancet. Child & Adolescent Health, vol. 4, no. 6, June 2020, pp. 412–14. EBSCOhost, https://doi.org/10.1016/S2352-4642(20)30110-3.

APA

Cortese, S., Asherson, P., Sonuga-Barke, E., Banaschewski, T., Brandeis, D., Buitelaar, J., Coghill, D., Daley, D., Danckaerts, M., Dittmann, R. W., Doepfner, M., Ferrin, M., Hollis, C., Holtmann, M., Konofal, E., Lecendreux, M., Santosh, P., Rothenberger, A., Soutullo, C., … Simonoff, E. (2020). ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group. The Lancet. Child & Adolescent Health, 4(6), 412–414. https://doi.org/10.1016/S2352-4642(20)30110-3

Chicago

Cortese, Samuele, Philip Asherson, Edmund Sonuga-Barke, Tobias Banaschewski, Daniel Brandeis, Jan Buitelaar, David Coghill, et al. 2020. “ADHD Management during the COVID-19 Pandemic: Guidance from the European ADHD Guidelines Group.” The Lancet. Child & Adolescent Health 4 (6): 412–14. doi:10.1016/S2352-4642(20)30110-3.